Trial Details
COMPLETEDBasic Information
| Clinical ID | c3639 |
|---|---|
| Identifier | NCT01751152 |
| Trial Title | A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy and Safety of NNC0114-0006 in Subjects With Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammation|Crohn's Disease |
| Interventions | DRUG: NNC0114-0006|DRUG: placebo |
Participant Information
| Sponsor | Novo Nordisk A/S |
|---|---|
| City | Tucson |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2013-02 |
|---|---|
| Primary Completion Date | 2014-12 |
| Completion Date | 2014-12 |